News

Filter

Current filters:

Ascletis Pharmaceuticals

Third deal for Ascletis, which gains China market rights from Janssen to a clinical stage HIV protease inhibitor

01-05-2013

USA and China-based biotech firm Ascletis Pharmaceuticals says it has licensed development, manufacturing…

Anti-viralsAscletis PharmaceuticalsAsia-PacificBiotechnologyJanssenJohnson & JohnsonLicensingTMC310911

Roche teams up with Ascletis on hep C treatments for China

15-04-2013

Roche (ROG: SIX) has entered a collaboration with Ascletis Pharmaceuticals, a USA- and China-based biotech…

Anti-viralsAscletis PharmaceuticalsAsia-PacificBiotechnologydanoprevirLicensingMarkets & MarketingPharmaceuticalResearchRoche

Alnylam and Ascletis collaborate to develop ALN-VSP for liver cancers in China

15-07-2012

US RNAi therapeutics specialties Alnylam Pharmaceuticals (Nasdaq: ALNY) and Ascletis Pharmaceuticals,…

ALN-VSPAlnylam PharmaceuticalsAscletis PharmaceuticalsAsia-PacificBiotechnologyLicensingOncology

USA and China-based Ascletis raises $100 million for specialty therapeutics venture

07-04-2011

Ascletis, a US-China specialty life sciences venture focused on cancer and infectious disease therapeutics,…

Ascletis PharmaceuticalsAsia-PacificFinancialLicensingNorth AmericaPharmaceuticalResearch

COMPANY SPOTLIGHT

Menarini

Back to top